These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1774 related articles for article (PubMed ID: 33945513)
21. Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Geldmacher C; Zumla A; Hoelscher M Curr Opin HIV AIDS; 2012 May; 7(3):268-75. PubMed ID: 22495739 [TBL] [Abstract][Full Text] [Related]
22. Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China. Li L; Zhang J; Sun R; Liu H; Cheng G; Fan F; Wang C; Li A; Liang H; Yu Z; Wang G; Ren Z BMC Public Health; 2024 Feb; 24(1):556. PubMed ID: 38388348 [TBL] [Abstract][Full Text] [Related]
23. Co-infection with Mycobacterium tuberculosis impairs HIV-Specific CD8+ and CD4+ T cell functionality. Chetty S; Govender P; Zupkosky J; Pillay M; Ghebremichael M; Moosa MY; Ndung'u T; Porichis F; Kasprowicz VO PLoS One; 2015; 10(3):e0118654. PubMed ID: 25781898 [TBL] [Abstract][Full Text] [Related]
24. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients. Oja AE; Saris A; Ghandour CA; Kragten NAM; Hogema BM; Nossent EJ; Heunks LMA; Cuvalay S; Slot E; Linty F; Swaneveld FH; Vrielink H; Vidarsson G; Rispens T; van der Schoot E; van Lier RAW; Ten Brinke A; Hombrink P Eur J Immunol; 2020 Dec; 50(12):1998-2012. PubMed ID: 33073359 [TBL] [Abstract][Full Text] [Related]
26. Tuberculosis specific responses following therapy for TB: Impact of HIV co-infection. Siddiqui S; Sarro Y; Diarra B; Diallo H; Guindo O; Dabitao D; Tall M; Hammond A; Kassambara H; Goita D; Dembele P; Traore B; Hengel R; Nason M; Warfield J; Washington J; Polis M; Diallo S; Dao S; Koita O; Lane HC; Catalfamo M; Tounkara A Clin Immunol; 2015 Jul; 159(1):1-12. PubMed ID: 25889622 [TBL] [Abstract][Full Text] [Related]
28. CD4 T Cells in McLaughlin TA; Khayumbi J; Ongalo J; Tonui J; Campbell A; Allana S; Gurrion Ouma S; Odhiambo FH; Gandhi NR; Day CL Front Immunol; 2020; 11():127. PubMed ID: 32117277 [No Abstract] [Full Text] [Related]
29. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients. Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W Front Immunol; 2021; 12():684014. PubMed ID: 34194438 [TBL] [Abstract][Full Text] [Related]
30. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y Front Immunol; 2020; 11():596684. PubMed ID: 33362779 [TBL] [Abstract][Full Text] [Related]
31. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Petrone L; Petruccioli E; Vanini V; Cuzzi G; Gualano G; Vittozzi P; Nicastri E; Maffongelli G; Grifoni A; Sette A; Ippolito G; Migliori GB; Palmieri F; Goletti D Int J Infect Dis; 2021 Dec; 113 Suppl 1():S82-S87. PubMed ID: 33713816 [TBL] [Abstract][Full Text] [Related]
32. TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection. Luke E; Swafford K; Shirazi G; Venketaraman V Front Biosci (Schol Ed); 2022 Mar; 14(1):6. PubMed ID: 35320917 [TBL] [Abstract][Full Text] [Related]
33. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells. Jung MK; Shin EC Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892 [TBL] [Abstract][Full Text] [Related]
35. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes. Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758 [TBL] [Abstract][Full Text] [Related]
36. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
37. Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection. Najafi-Fard S; Aiello A; Navarra A; Cuzzi G; Vanini V; Migliori GB; Gualano G; Cerva C; Grifoni A; Sette A; Vaia F; Palmieri F; Goletti D Int J Infect Dis; 2023 May; 130 Suppl 1():S34-S42. PubMed ID: 36944383 [TBL] [Abstract][Full Text] [Related]
38. T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess. Pena NM; Santana LC; Hunter JR; Blum VF; Vergara T; Gouvea C; Leal E; Bellei N; Schechter M; Diaz RS BMC Infect Dis; 2024 Jun; 24(1):612. PubMed ID: 38902613 [TBL] [Abstract][Full Text] [Related]
39. HIV Skews the Lineage-Defining Transcriptional Profile of Mycobacterium tuberculosis-Specific CD4+ T Cells. Riou C; Strickland N; Soares AP; Corleis B; Kwon DS; Wherry EJ; Wilkinson RJ; Burgers WA J Immunol; 2016 Apr; 196(7):3006-18. PubMed ID: 26927799 [TBL] [Abstract][Full Text] [Related]
40. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; Pinnetti C; Sampaolesi A; Antinori A; Girardi E; Goletti D J Infect; 2014 Dec; 69(6):533-45. PubMed ID: 24975174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]